Search
Now showing items 1-1 of 1
The novel toluidine sulphonamide el102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents mdr1 resistance
(Springer Nature, 2013-09-19)
Background: Taxanes are routinely used for the treatment of prostate cancer, however the majority of patients eventually develop resistance. We investigated the potential efficacy of EL102, a novel toluidine sulphonamide, ...